The risk of prostate cancer mortality and cardiovascular mortality of nonmetastatic prostate cancer patients: A population-based retrospective cohort study
To assess the risk of prostate cancer (PCa) specific mortality (PCSM) compared to cardiovascular disease mortality (CVDM), or other-cause mortality (OCM) of men with nonmetastatic PCa according to PCa risk groups, primary treatment, and age.
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Katarina L. Matthes, Giulia Pestoni, Dimitri Korol, Mieke Van Hemelrijck, Sabine Rohrmann Tags: Original article Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Prostate Cancer | Study | Urology & Nephrology